Combining proteasome inhibitors with autophagy inhibitors disrupts acute myeloid leukemia (AML) cells' proteostasis, enhancing treatment efficacy and inducing programmed cell death. The novel therapy ...

Researchers have discovered that the combination of the two cancer drugs Rapamycin and Trametinib significantly extends the lifespan of mice. This therapy shows greater effects than the individual ...

a team of researchers at Cedars-Sinai analyzed the combination of pembrolizumab, an immunotherapy drug known as Keytruda, with radiation therapy to identify patient response and understand changes in ...

Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences &Peking Union Medical College, conducted a multicenter comprehensive retrospective analysis to assess the ...

Affimed has decided to focus on testing AFM13 in combination with Artiva's AB-101 NK cell product for the treatment of peripheral T-cell lymphoma after underwhelming monotherapy data. Peripheral ...

GLP-1RA and SGLT2 inhibitor combination therapy was associated with better cardiorenal outcomes than monotherapy among patients with type 2 diabetes. The cardiorenal benefits of sodium-glucose ...

At the American Society of Clinical Oncology (ASCO) annual meeting, promising results were reported from two trials that evaluated a combination of two bispecific antibodies in patients with relapsed ...

An important new study has demonstrated that a combination therapy can slow cognitive decline in older adults at risk for dementia. An important new study led by the Centre for Addiction and Mental ...

Add Yahoo as a preferred source to see more of our stories on Google. For men facing the return of prostate cancer, a new combination therapy may offer a much longer break before the disease comes ...

Please provide your email address to receive an email when new articles are posted on . Relugolix combination therapy was associated with improved endometriosis pain for up to 2 years. Over 2 years, ...